Issue 41, 2024, Issue in Progress

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Abstract

Correction for ‘New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies’ by Heba W. Alhamdi et al., RSC Adv., 2024, 14, 28555–28568, https://doi.org/10.1039/D4RA04219K.

Associated articles

Article information

Article type
Correction
Submitted
12 Sep 2024
Accepted
12 Sep 2024
First published
19 Sep 2024
This article is Open Access
Creative Commons BY license

RSC Adv., 2024,14, 29890-29890

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

H. W. Alhamdi, M. Y. Alfaifi, A. A. Shati, S. E. I. Elbehairi, M. Er-rajy, R. F. M. Elshaarawy, Y. A. Hassan and R. Zakrya, RSC Adv., 2024, 14, 29890 DOI: 10.1039/D4RA90101K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements